What should be done once the target or maximum tolerated dose of an ARB is reached?
Once the target or maximum tolerated dose of an ARB is reached, it is recommended to monitor treatment monthly for 3 months and then at least every 6 months, and at any time the person becomes acutely unwell. It is also recommended to measure serum sodium and potassium and assess renal function before and after starting an MRA and after each dose increment, as well as measure blood pressure before and after each dose increment of MRA. It is also recommended to follow the recommendations on measuring blood pressure, including measurement in people with symptoms of postural hypotension, in the NICE guideline on hypertension in adults.